Skip to main content

Publications

125 publications

Active

1 grant
  • Co-I
    Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation
    Prostate Cancer Foundation · 2017–2027
    17CHAL11
Completed grants (20)
  • Co-I
    Sex Differences in the Molecular Determinants of Alzheimer’s Disease Risk
    National Institute on Aging · 2018–2024 · via University of Arizona
    R01AG057931-01A1
  • Co-I
    Biomarkers and Brain Mechanisms of Gulf War Illness
    U.S. Department of Defense · 2015–2022
    W81XWH-15-1-0437
  • MPI
    PET Measures of CSF Clearance in Alzheimer Disease
    National Institute on Aging · 2017–2022 · via New York University School of Medicine (Grossman)
    RF1AG057570-02
  • KP
    Sex Differences in the Molecular Determinants of AD Risk and Responsiveness to Treatment
    National Institute on Aging · 2016–2021 · via University of Arizona
    P01AG026572-11
  • KP
    A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients with High-Risk Castrate Biochemically Relapsed...
    U.S. Department of Defense · 2009–2019
    W81XWH-09-1-0596
  • PI
    Radiolabeled Exosomes for the Early Detection of Metastases and to Predict Breast Cancer Premetastatic Niche
    U.S. Department of Defense · 2013–2018
    W81XWH-13-1-0248
  • KP
    Intra-Arterial Gene Therapy for LINCL
    National Institute of Neurological Disorders and Stroke · 2015–2018
    R56NS082655-01A1
  • Sub-PI
    Clinical Correlates of Longitudinal PET Changes in AD
    National Institute on Aging · 2009–2017 · via New York University School of Medicine (Grossman)
    R01AG013616-22 EW
  • MPI
    Maternal History of Alzheimer's Predisposes Children to Amyloid Beta-Related Hypometabolism
    National Institute on Aging · 2010–2016 · via New York University - for Migration
    R01AG035137-05 EW
  • KP
    Brain Aromatase Availability in Steroid Users: PET Studies With [11C] Vorozole
    National Institute on Drug Abuse · 2013–2016 · via Mount Sinai School of Medicine
    R21DA032858-03
  • Sub-PI
    Pilot PET Study Characterizing [11C] Arachidonic Acid in Bipolar Disorder
    National Institute of Mental Health · 2012–2015 · via The Nathan S. Kline Institute
    R21MH096255-02 EW
  • KP
    Neuroinflammation, NMDA Receptors and Cognitive Function in Chemobrain
    National Cancer Institute · 2014–2015 · via Empire State College Foundation, Inc.
    R21CA179425-01A1
  • KP
    Neuroimaging and Metabolomics Correlates of Cognitive Decline in Parkinson's Disease
    National Institute of Neurological Disorders and Stroke · 2009–2015
    R01NS064038-01A1
  • PI
    Neurobiology of Depression and Antidepressants
    National Institute of Mental Health · 2010–2015
    R01MH040695-22 EW
  • KP
    Mechanisms of Recovery Following Severe Brain Injury
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2008–2014
    R01HD051912-05EWO
  • PI
    Imaging Neuroinflammation in Alzheimer's Disease (AD) with [11C] Arachidonic Acid and PET
    National Institute on Aging · 2009–2013
    RC2AG036502-02EWO
  • KP
    Fractionated, Dual-Targeted Radioimmunotherapy for Follicular Lymphoma
    National Cancer Institute · 2010–2013
    R21CA149978-02EWO
  • KP
    Translational Research on Eating Disorders: Reward Systems
    National Institute of Mental Health · 2011–2013 · via Research Foundation for Mental Hygiene, Inc.
    R01MH079397-05
  • KP
    ImmunoPET Based on Anti-PSMA Antibody, 89Zr-J591 for Molecular Imaging of Prostate Cancer
    National Cancer Institute · 2011–2012
    R21CA153177-01A1
  • PI
    Questionable Dementia II: Course and Predictors of Outcome
    National Institute on Aging · 2010–2011
    R01AG017761-14EWO